Hims & Hers Health, Inc. (HIMS) vs PDS Biotechnology Corporation (PDSB)
A side-by-side comparison of Hims & Hers Health, Inc. and PDS Biotechnology Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of August 31, 2026. Differences are shown without an overall score or investment verdict.
HIMS
Hims & Hers Health, Inc.
$28.84HealthcareAt close: Aug 28, 2026, 4:00 PM ET
PDSB
PDS Biotechnology Corporation
$0.21HealthcareAt close: Aug 28, 2026, 4:00 PM ET
Total return — HIMS vs PDSB
growth of $100 · dividends reinvested · last 7yHIMS +194.3% (+16.7%/yr)PDSB -96.0% (-36.9%/yr)HIMS compounded faster over this window
Log scale — wide-divergence pair
HIMS PDSB
HIMS vs PDSB: by the numbers
- •HIMS is the larger company ($6.43B vs $12M market cap).
- •Both run net losses; PDSB's is the smaller (0.00% vs -5.51% net margin).
Metrics side by side
Valuation
| Metric | HIMS | PDSB |
|---|---|---|
| P/S ratio | 2.59 | N/A |
| P/B ratio | 20.62 | 3.45 |
| EV / EBITDA | 81.70 | 0.02 |
| FCF yield | 1.34% | N/A |
Profitability
| Metric | HIMS | PDSB |
|---|---|---|
| Gross margin | 73.84% | 0.00% |
| Operating margin | 4.50% | 0.00% |
| Net margin | -5.51% | 0.00% |
| ROE | -43.83% | -372.85% |
| ROIC | -4.30% | -3699.99% |
Growth (annualized)
| Metric | HIMS | PDSB |
|---|---|---|
| Revenue CAGR (5Y) | 67.47% | N/A |
| Total return CAGR (5Y) | 30.11% | -57.05% |
Frequently asked
- How have HIMS and PDSB total returns compared?
- Over the past 5 years, HIMS delivered 30.11% and PDSB delivered -49.05% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Hims & Hers Health ROEPDS Biotechnology ROEHims & Hers Health operating marginPDS Biotechnology operating marginHims & Hers Health revenue growthPDS Biotechnology revenue growthHims & Hers Health free cash flowPDS Biotechnology free cash flow
Hims & Hers Health & PDS Biotechnology appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified August 31, 2026.